Trial intelligence / Profile preview

Promethazine + betahistine with or without Epley maneuver for peripheral vertigo

IRCT20221108056446N14Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of promethazine and betahistine in vertigo (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Speed of improvement in peripheral vertigo symptoms and Severity of improvement in peripheral vertigo symptoms. Started Mar 2025; status: completed.

02

Drugs

promethazinebetahistine
03

Conditions

vertigo

Beyond the preview

Go deeper on IRCT20221108056446N14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221108056446N14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call